Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 93

1.

Tackling Ethical Challenges of Premature Delivery of Stem Cell-Based Therapies: ISSCR 2018 Annual Meeting Focus Session Report.

Sugarman J, Barker RA, Kerridge I, Lysaght T, Pellegrini G, Sipp D, Tanner C.

Stem Cell Reports. 2018 Nov 13;11(5):1021-1025. doi: 10.1016/j.stemcr.2018.10.020.

2.

Ethical and policy issues in the clinical translation of stem cells: report of a focus session at the ISSCR Tenth Annual Meeting.

Kato K, Kimmelman J, Robert J, Sipp D, Sugarman J.

Cell Stem Cell. 2012 Dec 7;11(6):765-7. doi: 10.1016/j.stem.2012.11.004.

3.
4.
5.

Medical societies, patient education initiatives, public debate and marketing of unproven stem cell interventions.

Weiss DJ, Turner L, Levine AD, Ikonomou L.

Cytotherapy. 2018 Feb;20(2):165-168. doi: 10.1016/j.jcyt.2017.10.002. Epub 2017 Nov 24.

PMID:
29239793
6.

An interview with Irving Weissman at the 2010 ISSCR meeting. Interview by Eva Amsen.

Weissman I.

Development. 2010 Oct;137(20):3349-50. doi: 10.1242/dev.058198.

7.

Stem cells in the land of the rising sun: ISSCR 2012.

Plath K, Srivastava D, Alvarez-Buylla A, Tanaka EM, Kriegstein AR.

Cell Stem Cell. 2012 Nov 2;11(5):607-14. doi: 10.1016/j.stem.2012.10.003.

8.

On the streets of San Francisco: highlights from the ISSCR Annual Meeting 2010.

Elefanty AG, Blelloch R, Passegué E, Wernig M, Mummery CL.

Cell Stem Cell. 2010 Oct 8;7(4):443-50. doi: 10.1016/j.stem.2010.09.002.

9.

ISSCR 2009 Industry Panel Session: promoting translation and commercialization.

Mason C.

Cell Stem Cell. 2009 Oct 2;5(4):379-84. doi: 10.1016/j.stem.2009.09.006.

10.

Molecular insights into the function, fate, and prospects of stem cells.

Rajasekhar VK, Vemuri MC.

Stem Cells. 2005 Sep;23(8):1212-20. Epub 2005 Aug 2.

11.

[Bioethical challenges of stem cell tourism].

Ventura-Juncá P, Erices A, Santos MJ.

Rev Med Chil. 2013 Aug;141(8):1034-40. doi: 10.4067/S0034-98872013000800010. Review. Spanish.

13.

Unproven stem cell-based interventions and achieving a compromise policy among the multiple stakeholders.

Matthews KR, Iltis AS.

BMC Med Ethics. 2015 Nov 4;16(1):75. doi: 10.1186/s12910-015-0069-x. Review.

14.

Stem cell therapies in clinical trials: workshop on best practices and the need for harmonization.

Martell K, Trounson A, Baum E.

Cell Stem Cell. 2010 Oct 8;7(4):451-4. doi: 10.1016/j.stem.2010.09.004.

15.

International coordination of large-scale human induced pluripotent stem cell initiatives: Wellcome Trust and ISSCR workshops white paper.

Soares FA, Sheldon M, Rao M, Mummery C, Vallier L.

Stem Cell Reports. 2014 Dec 9;3(6):931-9. doi: 10.1016/j.stemcr.2014.11.006.

16.

Stem cells shine in Shanghai.

Cheng L, Xiao L, Zeng F, Zhang YA.

Cell Stem Cell. 2008 Jan 10;2(1):34-7. doi: 10.1016/j.stem.2007.12.010.

18.

The roles and responsibilities of physicians in patients' decisions about unproven stem cell therapies.

Levine AD, Wolf LE.

J Law Med Ethics. 2012 Spring;40(1):122-34. doi: 10.1111/j.1748-720X.2012.00650.x.

PMID:
22458467
19.

No borders, only frontiers: the Global Stem Cell Research Community and the ISSCR.

Sipp D.

Cell Stem Cell. 2007 Jun 7;1(1):53-4. doi: 10.1016/j.stem.2007.05.002.

20.

A summary on stem cell research: a report on the 8th Annual Meeting of the International Society for Stem Cell Research.

Romano G.

Drug News Perspect. 2010 Sep;23(7):465-8. doi: 10.1358/dnp.2010.23.7.1519653.

PMID:
20862399

Supplemental Content

Support Center